Shenzhen Jifu Pharmaceutical

Shenzhen Jifu Pharmaceutical Co., Ltd. (also known as Shenzhen Zifu Pharmaceutical) is a pharmaceutical company based in Shenzhen, China, specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2004, the company operates multiple production lines for tablets, capsules, granules, and lyophilized powders, with a focus on small molecule therapeutics. Its product portfolio includes Zonisamide for epilepsy, Amifostine for cytoprotection in oncology, and Incadronate disodium for bone-related conditions. The company is headquartered in the Dapeng New District of Shenzhen and maintains GMP-certified manufacturing facilities that support its role in the global API supply chain.